BACKGROUND: The impact of race and socioeconomic status (SES) in prostate cancer (CaP) outcomes has been well-studied, but controversy remains. The associations of race/SES with intermediate CaP outcomes, including positive surgical margin (PSM) and biochemical recurrence (BCR), were explored in an equal-access setting. METHODS: Data were retrospectively collected from 2502 men in the Shared Equal Access Regional Cancer Hospitals (SEARCH) database who underwent radical prostatectomy from 1989 to 2010. SES (income, education, employment, and poverty) was estimated from linkage of home ZIP code to census data. Logistic regression with adjustment for pre- and postoperative covariates estimated risk for associations between race/SES and pathologic outcomes. Cox proportional hazards models estimated risk for associations between race/SES and time to BCR. RESULTS: Black men were more likely to have lower SES than white men (P < .001). On multivariate analysis, race was not associated with PSM, but higher SES was associated with less PSM and fewer Gleason sum ≥ 7 pathologic tumors when SES was assessed by education, employment, or poverty (P trend ≤ .051) and income, employment, or poverty (P trend ≤ 0.059), respectively. Crude Cox models showed black men had higher BCR risk (hazards ratio = 1.20, 95% confidence interval = 1.05-1.38, P = .009) that persisted after adjustment for covariates including SES (hazards ratio ≥ 1.18, P ≤ .040). Higher SES measured by income and poverty were associated with less BCR, but only for black men (P trend ≤ .048). CONCLUSIONS: Even in an equal-access setting, higher SES predicted lower PSM risk, and race persisted in predicting BCR despite adjustment for SES. Low SES black patients may be at greatest risk for postprostatectomy BCR.
BACKGROUND: The impact of race and socioeconomic status (SES) in prostate cancer (CaP) outcomes has been well-studied, but controversy remains. The associations of race/SES with intermediate CaP outcomes, including positive surgical margin (PSM) and biochemical recurrence (BCR), were explored in an equal-access setting. METHODS: Data were retrospectively collected from 2502 men in the Shared Equal Access Regional Cancer Hospitals (SEARCH) database who underwent radical prostatectomy from 1989 to 2010. SES (income, education, employment, and poverty) was estimated from linkage of home ZIP code to census data. Logistic regression with adjustment for pre- and postoperative covariates estimated risk for associations between race/SES and pathologic outcomes. Cox proportional hazards models estimated risk for associations between race/SES and time to BCR. RESULTS: Black men were more likely to have lower SES than white men (P < .001). On multivariate analysis, race was not associated with PSM, but higher SES was associated with less PSM and fewer Gleason sum ≥ 7 pathologic tumors when SES was assessed by education, employment, or poverty (P trend ≤ .051) and income, employment, or poverty (P trend ≤ 0.059), respectively. Crude Cox models showed black men had higher BCR risk (hazards ratio = 1.20, 95% confidence interval = 1.05-1.38, P = .009) that persisted after adjustment for covariates including SES (hazards ratio ≥ 1.18, P ≤ .040). Higher SES measured by income and poverty were associated with less BCR, but only for black men (P trend ≤ .048). CONCLUSIONS: Even in an equal-access setting, higher SES predicted lower PSM risk, and race persisted in predicting BCR despite adjustment for SES. Low SES black patients may be at greatest risk for postprostatectomy BCR.
Authors: Andrew Vickers; Fernando Bianco; Angel Cronin; James Eastham; Eric Klein; Michael Kattan; Peter Scardino Journal: J Urol Date: 2010-02-19 Impact factor: 7.450
Authors: Sima P Porten; Damien A Richardson; Anobel Y Odisho; Jack W McAninch; Peter R Carroll; Matthew R Cooperberg Journal: J Urol Date: 2010-09-17 Impact factor: 7.450
Authors: Anobel Y Odisho; Matthew R Cooperberg; Vincent Fradet; Ardalan E Ahmad; Peter R Carroll Journal: J Clin Oncol Date: 2010-04-20 Impact factor: 44.544
Authors: David C Miller; Mark S Litwin; Jonathan Bergman; Sevan Stepanian; Sarah E Connor; Lorna Kwan; William J Aronson Journal: J Urol Date: 2008-12-18 Impact factor: 7.450
Authors: Kathy S Albain; Joseph M Unger; John J Crowley; Charles A Coltman; Dawn L Hershman Journal: J Natl Cancer Inst Date: 2009-07-07 Impact factor: 13.506
Authors: Silke Hermann; Sabine Rohrmann; Jakob Linseisen; Anne M May; Anton Kunst; Herve Besson; Dora Romaguera; Noemie Travier; Maria-Jose Tormo; Esther Molina; Miren Dorronsoro; Aurelio Barricarte; Laudina Rodríguez; Francesca L Crowe; Kay-Tee Khaw; Nicholas J Wareham; Petra G A van Boeckel; H Bas Bueno-de-Mesquita; Kim Overvad; Marianne Uhre Jakobsen; Anne Tjønneland; Jytte Halkjær; Claudia Agnoli; Amalia Mattiello; Rosario Tumino; Giovanna Masala; Paolo Vineis; Androniki Naska; Philippos Orfanos; Antonia Trichopoulou; Rudolf Kaaks; Manuela M Bergmann; Annika Steffen; Bethany Van Guelpen; Ingegerd Johansson; Signe Borgquist; Jonas Manjer; Tonje Braaten; Guy Fagherazzi; Françoise Clavel-Chapelon; Traci Mouw; Teresa Norat; Elio Riboli; Sabina Rinaldi; Nadia Slimani; Petra H M Peeters Journal: BMC Public Health Date: 2011-03-17 Impact factor: 3.295
Authors: Mohamed H Kamel; Milan Bimali; Mahmoud I Khalil; Ehab Eltahawy; LJoseph Su; Nabil K Bissada; Rodney Davis Journal: Int Urol Nephrol Date: 2019-03-06 Impact factor: 2.370
Authors: Jennifer M Knight; Karen L Syrjala; Navneet S Majhail; Michael Martens; Jennifer Le-Rademacher; Brent R Logan; Stephanie J Lee; Paul B Jacobsen; William A Wood; Heather S L Jim; John R Wingard; Mary M Horowitz; Muneer H Abidi; Mingwei Fei; Laura Rawls; J Douglas Rizzo Journal: Biol Blood Marrow Transplant Date: 2016-08-23 Impact factor: 5.742
Authors: David Schreiber; Eric B Levy; David Schwartz; Justin Rineer; Andrew Wong; Marvin Rotman; Jeffrey P Weiss Journal: Int Urol Nephrol Date: 2014-06-27 Impact factor: 2.370
Authors: Peter S Kirk; Tudor Borza; Megan E V Caram; Dean A Shumway; Danil V Makarov; Jennifer A Burns; Jeremy B Shelton; John T Leppert; Christina Chapman; Michael Chang; Brent K Hollenbeck; Ted A Skolarus Journal: BJU Int Date: 2018-11-12 Impact factor: 5.588